HIF1A and breast carcinoma: Our study reports herein that not only tamoxifen-resistant breast cancer cells display altered glycolysis compared to tamoxifen-sensitive cells but also Akt/mTOR and AMPK signaling molecules are attributed to HIF-1α-regulated glucose metabolism in these cells.